ARTICLE | Finance
IPO Watch
French companies Deinove and Neovacs update terms for Euronext IPOs
April 12, 2010 7:00 AM UTC
Two French companies updated their IPO terms last week, as bioprocessing play Deinove and autoimmune and inflammation company Neovacs S.A. aim to complete their deals over the next two weeks.
Deinove is using deinococci bacteria to develop technologies to make biofuels and antibiotics, which are in discovery. It is seeking to raise about €12 million ($16.2 million) through the sale of 1.4 million shares at €7.50-€9.16 in an IPO on Euronext Paris...